Open-label inteRventional Clinical Trial to Assess Efficacy and Safety of the exteMporaneous combInation of Nebivolol and Ramipril in hypertenSIve pAtients

NCT06104423 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

266

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Nebivolol 5 mg
DRUG: Ramipril 2.5/5/10 mg

Sponsor

Menarini International Operations Luxembourg SA